Geneva, Switzerland

Cristina De Min


Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Cristina De Min: Innovator in Medical Treatments

Introduction

Cristina De Min is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of medical treatments, particularly in relation to interferon-gamma related indications. With a total of three patents to her name, her work has the potential to impact the lives of many patients.

Latest Patents

Cristina's latest patents include innovative methods and compositions for treating or preventing conditions associated with elevated levels of interferon-gamma (IFN-γ). One of her notable patents focuses on methods, compositions, and dosing regimens aimed at treating, preventing, or alleviating symptoms related to elevated IFN-γ levels. Another patent addresses the diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers. This includes methods for treating hemophagocytic lymphohistiocytosis (HLH) and other related disorders.

Career Highlights

Throughout her career, Cristina has worked with notable companies such as Swedish Orphan Biovitrum AG. Her expertise in the field has allowed her to develop groundbreaking treatments that address critical health issues.

Collaborations

Cristina has collaborated with esteemed colleagues, including Walter Ferlin and Fabrizio De Benedetti. These partnerships have further enhanced her research and development efforts in the medical field.

Conclusion

Cristina De Min is a trailblazer in the realm of medical innovations, with her patents paving the way for new treatments and therapies. Her work exemplifies the impact that dedicated inventors can have on healthcare and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…